1610056-01-3
中文名称
1610056-01-3
英文名称
Peptide T TFA
CAS
1610056-01-3
分子式
C37H56F3N9O18
分子量
971.9
MOL 文件
1610056-01-3.mol
1610056-01-3 结构式
1610056-01-3价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2023/03/20 | HY-P0272A | 1610056-01-3 Peptide T TFA | 1610056-01-3 | 1mg | 1000元 |
| 2023/03/20 | HY-P0272A | 1610056-01-3 Peptide T TFA | 1610056-01-3 | 5mg | 2900元 |
| 2023/03/20 | HY-P0272A | 1610056-01-3 Peptide T TFA | 1610056-01-3 | 10mg | 4900元 |
常见问题列表
生物活性
Peptide T (TFA) 是源自HIV-1 gp120的V2区的八肽。 Peptide T是 CD4 受体的配体，可阻止 HIV 与CD4受体结合。靶点
CD4, HIV
体外研究
Peptide T acts to block viral entry as it inhibits in the MAGI cell assay and blocks infection in the luciferase reporter assay using HIV virions pseudotyped with ADA envelope. Peptide T selectively inhibits HIV replication using chemokine receptor CCR5 compared to CXC4. Peptide T at 10 -8 M induces IL-10 production by the human Th2 cell line and PBMC. Also peptide T at 10 -9 M concentration significantly inhibits IFN-g production by PBMC.
体内研究
Peptide T is administered subcutaneously at different doses and phases of the experimental autoimmune encephalomyelitis (EAE) disease, but Peptide T neither prevents nor ameliorates EAE.